"When it comes to choosing a physician, patients look for someone with whom they can trust and who has superior training and experience. If they happen to be a leader in their field, that’s even better yet. Kenneth M. Reed, MD, founder of DermASAP with offices in Quincy and Plymouth, Massachusetts, is that and so much more. Dr. Reed is a board-certified dermatologist and fellow of the American Academy of Dermatology who founded DermASAP on the premise that patients shouldn’t have to wait weeks or months for diagnosis or treatment for serious skin conditions."

During the past decade, Kenneth M. Reed, MD conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Kenneth M. Reed, MD" are "Atopic Dermatitis" (1 trials) and "Psoriasis" (1 trials). Many other conditions were trialed in "Kenneth M. Reed, MD" in a lesser frequency.

Most popular intervention types in "Kenneth M. Reed, MD" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Alefacept exposure" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kenneth M. Reed, MD" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Kenneth M. Reed, MD". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Kenneth M. Reed, MD, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Kenneth M. Reed, MD, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".